Fowl Cholera (Pasteurella multocida) in Poultry and Backyard Flocks: Clinical Presentation, Pathogenesis, and Control

Etiology

Fowl cholera is a contagious bacterial disease of domestic and wild birds caused by Pasteurella multocida, a Gram-negative, non-motile, facultatively anaerobic coccobacillus [1, 2]. The bacterium possesses a polysaccharide capsule and expresses a lipopolysaccharide (LPS) outer core that is critical for virulence and serotyping [3, 4]. P. multocida is classified into five capsular serogroups (A, B, D, E, F) and 16 somatic serotypes based on LPS antigens, with serogroup A being the most common cause of fowl cholera in poultry [5, 6]. The organism is a member of the family Pasteurellaceae and is closely related to other pathogenic species such as Mannheimia haemolytica and Gallibacterium anatis [7, 8].

The term "chicken pox bacteria name" is a misnomer that requires clarification. Chickenpox in humans is caused by the varicella-zoster virus (a herpesvirus), not a bacterium. In poultry, the disease known as fowl pox is caused by an avipoxvirus, and it is distinct from fowl cholera. No bacterial agent is responsible for chickenpox in any species. This article focuses exclusively on the bacterial pathogen P. multocida.

Epidemiology

Fowl cholera occurs worldwide and is considered a significant cause of morbidity and mortality in commercial poultry and backyard flocks [9, 10]. The disease is often described as a poultry pandemic due to its global distribution and ability to cause explosive outbreaks with high mortality [11, 8]. Outbreaks have been documented in chickens, turkeys, ducks, geese, and numerous wild bird species [7, 12]. Turkeys are particularly susceptible, often experiencing higher mortality rates than chickens [7, 5]. A 100% mortality rate was reported in a commercial slow-growing broiler chicken flock during an acute fowl cholera outbreak [11].

Transmission occurs horizontally through direct contact, inhalation of aerosolized respiratory secretions, or ingestion of contaminated feed and water [9, 13]. The bacterium is shed in oral, nasal, and conjunctival exudates as well as in chicken feces bacteria, which can contaminate the environment and serve as a source of infection for naive birds [9, 14]. Chronic carrier birds are a critical reservoir for maintaining infection within and between flocks [13, 12]. Land cover and environmental factors, such as proximity to wetlands and wild waterfowl habitats, have been associated with increased risk of fowl cholera outbreaks [13, 12]. The dynamics of cholera transmission in poultry farms have been modeled using compartmental approaches, demonstrating that rapid detection and isolation are essential for outbreak control [9].

Clinical Presentation

The clinical presentation of fowl cholera varies with the virulence of the P. multocida strain, host species, age, and immune status [11, 15]. Three main forms are recognized: peracute, acute, and chronic.

Peracute Form

The peracute form is characterized by sudden death without premonitory signs [11, 10]. Birds are often found dead in good body condition, and mortality can spike rapidly within 24 to 48 hours [11]. This form is more common in highly susceptible species such as turkeys and in naive flocks [7, 11].

Acute Form

The acute form is the most frequently observed presentation in commercial poultry [14, 10]. Clinical signs include fever, depression, anorexia, ruffled feathers, and cyanosis of the comb and wattles [11, 10]. Respiratory signs such as dyspnea, rales, and mucoid nasal discharge are common [7, 14]. Diarrhea, initially watery and later becoming mucoid or hemorrhagic, is frequently observed [10, 15]. Affected birds may exhibit lameness due to septic arthritis [11, 10]. Mortality rates in acute outbreaks typically range from 20% to 50% but can approach 100% in untreated flocks [11, 8].

Chronic Form

Chronic fowl cholera develops in birds that survive the acute phase or in flocks with endemic infection [10, 16]. Localized infections include swollen wattles (wattle edema), conjunctivitis, sinusitis, torticollis from otitis media or meningitis, and lameness from synovitis or osteomyelitis [11, 10]. Chronic respiratory disease and reduced egg production are also reported in layer flocks [16, 15].

Pathogenesis

Following inhalation or ingestion, P. multocida colonizes the upper respiratory tract mucosa and invades the underlying tissues [17, 18]. The polysaccharide capsule and LPS are key virulence factors that protect the bacterium from phagocytosis and complement-mediated killing [3, 4]. The hyaluronic acid capsule, encoded by the hya operon, is essential for full virulence, and the activity of the HyaD protein has been shown to contribute to the virulence of avian P. multocida [19, 4]. The stringent response, mediated by the alarmone (p)ppGpp, negatively regulates capsule production, indicating a complex regulatory network controlling virulence factor expression [4].

The bacterium produces a potent dermonecrotic toxin (Pasteurella multocida toxin, PMT) that acts as a mitogen, constitutively activating heterotrimeric G proteins and stimulating cellular proliferation [18]. PMT is a key virulence factor in toxigenic strains associated with progressive atrophic rhinitis in swine, but its role in avian fowl cholera is less clear [18]. Filamentous hemagglutinin B1 (FhaB1), an adhesin, has been investigated in turkey poults, but the fhaB1 gene was not found to be involved with avian fowl cholera pathogenesis in that model [17]. Phase variation in glycosyltransferase genes involved in LPS outer core biosynthesis has been linked to outbreaks on free-range layer farms, suggesting that antigenic variation contributes to immune evasion and persistence [16].

Once systemic invasion occurs, P. multocida multiplies rapidly in the bloodstream, leading to septicemia, endotoxic shock, and disseminated intravascular coagulation [11, 18]. The resulting vascular damage causes widespread petechial hemorrhages, serosanguinous exudates, and necrosis in multiple organs [11, 10].

Pathology

Gross lesions in acute fowl cholera are characteristic of septicemia [11, 10]. Petechial hemorrhages are present on the epicardium, serosal surfaces, and skeletal muscle [11, 10]. The liver is often enlarged, friable, and studded with multiple small, pale foci of necrosis (miliary necrosis) [11, 10]. The spleen may be enlarged and mottled [10]. Pneumonia and airsacculitis are common, particularly in turkeys [7, 5]. In chronic cases, localized lesions include caseous exudates in the wattles, sinuses, and joints [11, 10]. Fibrinous pericarditis and perihepatitis may also be observed [7].

Histologically, acute cases show fibrinoid necrosis of blood vessels, thrombosis, and multifocal necrosis in the liver, spleen, and lungs [11, 10]. Heterophilic infiltration is prominent in affected tissues [10].

Diagnostics

Definitive diagnosis of fowl cholera requires isolation and identification of P. multocida from clinical specimens [14, 10]. Samples should be collected aseptically from heart blood, liver, spleen, bone marrow, or localized lesions [14, 10]. The bacterium grows readily on blood agar or tryptic soy agar under aerobic or microaerophilic conditions, producing characteristic small, dewdrop-like colonies with a distinctive odor [14, 10]. Gram staining reveals Gram-negative coccobacilli [14].

Molecular Detection

Molecular methods offer rapid and sensitive detection. Conventional PCR targeting the kmt1 gene (species-specific) and capsular typing PCR are widely used for confirmation and serogroup determination [14, 20, 21]. Loop-mediated isothermal amplification (LAMP) assays have been developed and compared favorably with PCR for detecting P. multocida in poultry, offering the advantage of field-deployable testing without the need for thermal cyclers [21]. Genomic profiling and whole-genome sequencing provide high-resolution typing for epidemiological investigations and antimicrobial resistance gene detection [1, 2, 3].

Serological Detection

Commercial ELISA kits and in-house indirect ELISA assays are used to detect antibodies against P. multocida in chicken sera, aiding in flock-level surveillance and vaccine response monitoring [22, 23]. The lipoprotein E (PlpE) antigen has been identified as a promising target for serological assays due to its immunogenicity [24, 25].

Differential Diagnosis

Fowl cholera must be differentiated from other causes of acute septicemia in poultry, including avian influenza, Newcastle disease, fowl typhoid (caused by Salmonella Gallinarum), pullorum disease (Salmonella Pullorum), and colibacillosis (Escherichia coli) [11, 8]. Chronic forms should be distinguished from infectious coryza (Avibacterium paragallinarum), mycoplasmosis, and aspergillosis [7, 8].

Treatment

Antimicrobial therapy is the primary treatment for acute fowl cholera outbreaks [2, 14]. Historically, tetracyclines, sulfonamides, and penicillins have been used, but antimicrobial resistance (AMR) is an increasing concern [2, 20, 10]. Multidrug-resistant P. multocida strains have been isolated from poultry and rabbits, harboring resistance genes against tetracyclines, beta-lactams, aminoglycosides, and sulfonamides [2, 20]. Antibiogram profiling is essential for guiding effective therapy [14, 10]. In Ethiopia, high levels of resistance to tetracycline and ampicillin were reported among isolates from breeder chickens [14, 10]. In China, genomic characterization of avian P. multocida revealed diverse AMR determinants and mobile genetic elements [2].

Alternative therapeutic approaches are being explored. Novel multi-strain probiotics have been shown to reduce fowl cholera mortality in broilers, likely through competitive exclusion and immune modulation [26]. Plant-derived compounds, such as wild Egyptian artichoke extract, have demonstrated in vitro antibacterial activity against P. multocida [27]. These strategies may offer adjunctive or alternative options in the face of rising AMR.

Control and Prevention

Control of fowl cholera relies on a combination of biosecurity, management practices, and vaccination [9, 8].

Biosecurity

Strict biosecurity measures are critical to prevent introduction and spread of P. multocida [9, 13]. These include all-in/all-out production, cleaning and disinfection of facilities, rodent and wild bird control, and quarantine of new or returning birds [9, 13]. The question "does chicken get bacteria" is answered affirmatively; chickens are susceptible to P. multocida and can carry the bacterium without showing clinical signs, acting as subclinical shedders [9, 12]. Understanding "what kills chicken bacteria" involves recognizing that P. multocida is susceptible to common disinfectants such as quaternary ammonium compounds, bleach, and glutaraldehyde, provided organic matter is removed prior to application [9, 8].

Vaccination

Vaccination is a cornerstone of fowl cholera control in endemic areas [28, 29]. Both inactivated (bacterin) and live attenuated vaccines are available [28, 29, 5]. Inactivated vaccines are typically multivalent, containing multiple serotypes, and require adjuvants to enhance immunogenicity [29, 30]. Gel 01 hydrogel inactivated vaccines have been evaluated for their immunoprotective effect in chickens [29]. Gamma-irradiated fowl cholera vaccines, formulated with various adjuvants, have induced robust antibody responses and cytokine expression in chickens [23, 31]. Live attenuated vaccines, such as the serial passage-derived strain PMZ8, have shown promise in ducks [28]. Subunit vaccines targeting immunogenic proteins like PlpE, with or without flagellin as an adjuvant, have demonstrated efficacy in experimental settings [24, 25]. A strain with a truncated LPS outer core has also been evaluated as a vaccine candidate in ducks [32].

Vaccination strategies must be tailored to the specific serotypes circulating in a region [5, 6]. Autogenous vaccines prepared from local isolates are sometimes used when commercial vaccines fail to provide adequate protection [5].

Antimicrobial Stewardship

Given the rising prevalence of AMR, antimicrobial stewardship is essential [2, 20]. Routine prophylactic use of antibiotics should be avoided, and therapeutic use should be guided by culture and sensitivity testing [14, 10]. The question "ground chicken bacteria" refers to the potential contamination of ground poultry meat with P. multocida and other bacteria, underscoring the importance of proper cooking and handling to prevent foodborne transmission, although P. multocida is primarily an animal pathogen [33, 8].

Public Health Considerations

P. multocida is a zoonotic pathogen capable of causing localized infections in humans following bites, scratches, or contact with infected animals [33]. Cases of P. multocida bacteremia following a scratch by an adopted Pekin duck have been reported [33]. Immunocompromised individuals are at higher risk for severe disease [33]. Proper hygiene and protective measures should be employed when handling sick birds or contaminated materials.

Conclusion

Fowl cholera remains a major threat to poultry health and production worldwide. The term "fowl cholera in hindi" translates to "मुर्गी हैजा" (murghi haiza), reflecting its recognition in diverse linguistic and agricultural contexts. Advances in molecular diagnostics, genomic epidemiology, and vaccine development are improving our ability to detect, characterize, and control this disease. However, the emergence of multidrug-resistant strains and the complex epidemiology involving wild bird reservoirs necessitate ongoing surveillance and adaptive control strategies.

flowchart TD
    A[Clinical suspicion of fowl cholera], > B[Collect samples: heart blood, liver, spleen, bone marrow]
    B, > C[Gram stain: Gram-negative coccobacilli]
    C, > D[Culture on blood agar: dewdrop colonies]
    D, > E[Biochemical identification or MALDI-TOF]
    E, > F[PCR: kmt1 gene confirmation]
    F, > G[Capsular typing PCR: serogroup A, B, D, E, F]
    G, > H[Antimicrobial susceptibility testing]
    H, > I[Select appropriate antimicrobial therapy]
    I, > J[Implement biosecurity and vaccination]
    J, > K[Monitor flock for recurrence]

References

[1] Islam MA, Haque ME, Iftehimul M, et al. Genomic profiling of Pasteurella multocida strains isolated from ISA Brown (Gallus gallus domesticus) in Bangladesh. Microbiol Resour Announc. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41920836/

[2] Miao F, Dai B, Li Z, et al. Antimicrobial resistance and genomic characteristics of avian Pasteurella multocida. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41637789/

[3] Hashish A, Johnson TJ, Ghanem M, et al. Complete genome sequences of eight Pasteurella multocida isolates representing all lipopolysaccharide outer core loci. Microbiol Resour Announc. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39365089/

[4] Smallman TR, Williams GC, Harper M, et al. Genome-Wide Investigation of Pasteurella multocida Identifies the Stringent Response as a Negative Regulator of Hyaluronic Acid Capsule Production. Microbiol Spectr. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35404102/

[5] Semmate N, Bamouh Z, Elkarhat Z, et al. Isolation and Characterization of Pasteurella multocida A from an Outbreak in Turkeys in Morocco and Vaccine Preparation and Evaluation. Avian Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40643939/

[6] Saha O, Islam MR, Rahman MS, et al. First report from Bangladesh on genetic diversity of multidrug-resistant Pasteurella multocida type B:2 in fowl cholera. Vet World. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34840474/

[7] Gornatti-Churria CD, Jerry C, Ramsubeik S, et al. High mortality in a commercial turkey flock associated with coinfection by Pasteurella multocida and Mycoplasmoides (Mycoplasma) gallisepticum. J Vet Diagn Invest. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40996859/

[8] Fasina YO, Suarez DL, Ritter GD, et al. Unraveling frontiers in poultry health (part 1) - Mitigating economically important viral and bacterial diseases in commercial Chicken and Turkey production. Poult Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38417326/

[9] Malek A. Dynamics of cholera transmission in poultry farm: insights from a compartmental model and control strategies. Br Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40960429/

[10] Geda AM. Fowl Cholera in Chickens: Current Trends in Diagnosis and Phenotypic Drug Resistance in Gondar City, Ethiopia. Vet Med Int. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39669206/

[11] Miller I, Jerry C, Nguyen V, et al. 100% Mortality in Commercial Slow-Growing Broiler Chickens with Acute Fowl Cholera. Avian Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40643942/

[12] Allen JL, Bushell RN, Noormohammadi AH, et al. Pasteurella multocida ST20 is widespread in Australian poultry farms and may infect wild waterbirds. Vet Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38228079/

[13] Ouyang L, Campler MR, Wong S, et al. Exploring the Impact of Land Cover on the Occurrence of Ornithobacteriosis and Fowl Cholera: A Case-Case Study. Animals (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39943166/

[14] Geda AM, Wendimu A, Lulie S, et al. Molecular Detection and Antibiogram Profiling of Pasteurella multocida Isolated From Breeder Chickens Suspected of Fowl Cholera in Gondar City, Ethiopia. Int J Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40297765/

[15] Kannaki TR, Priyanka E, Haunshi S. Research Note: Disease tolerance/resistance and host immune response to experimental infection with Pasteurella multocida A:1 isolate in Indian native Nicobari chicken breed. Poult Sci. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34217907/

[16] Omaleki L, Blackall PJ, Cuddihy T, et al. Phase variation in the glycosyltransferase genes of Pasteurella multocida associated with outbreaks of fowl cholera on free-range layer farms. Microb Genom. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35266868/

[17] Dassanayake RP, Briggs RE, Kaplan BS, et al. Pasteurella multocida filamentous hemagglutinin B1 (fhaB1) gene is not involved with avian fowl cholera pathogenesis in turkey poults. BMC Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40140814/

[18] Kubatzky KF. Pasteurella multocida toxin - lessons learned from a mitogenic toxin. Front Immunol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36591313/

[19] Gao P, Wang L, Wang S, et al. The activity of hyaD contributed to the virulence of avian Pasteurella multocida. Microb Pathog. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38960217/

[20] El-Tarabili RM, Enany ME, Alenzi AM, et al. Unveiling resistance patterns, kmt1 sequence analyses, virulence traits, and antibiotic resistance genes of multidrug-resistant Pasteurella multocida retrieved from poultry and rabbits. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39948418/

[21] Poussard M, Pant SD, Huang J, et al. Comparative evaluation of PCR and loop-mediated isothermal amplification (LAMP) assays for detecting Pasteurella multocida in poultry. N Z Vet J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39448061/

[22] Beyene D, Shite A, Getachew B. Development and optimization of in-house made indirect ELISA kit for the detection of antibodies against Pasteurella multocida in chicken. BMC Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724974/

[23] Belay E, Bitew M, Ibrahim SM, et al. Gamma-irradiated fowl cholera vaccines formulated with different adjuvants induced antibody response and cytokine expression in chickens. Front Immunol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40103817/

[24] Chung YC, Cheng LT, Chu CY, et al. Flagellin Enhances the Immunogenicity of Pasteurella multocida Lipoprotein E Subunit Vaccine. Avian Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39400212/

[25] Cheng LT, Chu CY, Vu-Khac H, et al. Signal sequence contributes to the immunogenicity of Pasteurella multocida lipoprotein E. Poult Sci. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36423524/

[26] Reuben RC, Sarkar SL, Ibnat H, et al. Novel multi-strain probiotics reduces Pasteurella multocida induced fowl cholera mortality in broilers. Sci Rep. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33903662/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[27] Wahdan A, Elsebai MF, Elhaig MM, et al. Innovative use of wild Egyptian artichoke extract to control fowl cholera in vitro. Vet World. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40182829/

[28] Ji X, Meng Y, Yang H, et al. Attenuation mechanisms and vaccine potential of the serial passage-derived Pasteurella multocida strain PMZ8 in ducks. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41747463/

[29] Chen J, Sun Y, Hu Y, et al. Evaluation of the immunoprotective effect of gel 01 hydrogel inactivated vaccine against Pasteurella multocida infection in chickens. Microb Pathog. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40934985/

[30] Ghadimipour R, Ghorbanpoor M, Gharibi D, et al. Effects of Selected Adjuvants on Immunogenicity and Protectivity of Pasteurella multocida Bacterin Vaccine in Chickens. Arch Razi Inst. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/35096310/

[31] Dessalegn B, Bitew M, Asfaw D, et al. Gamma-Irradiated Fowl Cholera Mucosal Vaccine: Potential Vaccine Candidate for Safe and Effective Immunization of Chicken Against Fowl Cholera. Front Immunol. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34917086/

[32] Zhao X, Yang F, Shen H, et al. Immunogenicity and protection of a Pasteurella multocida strain with a truncated lipopolysaccharide outer core in ducks. Vet Res. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35236414/

[33] Bathobakae L, Cho H, Philip S, et al. Friend Turned Foe: Pasteurella multocida Bacteremia Following a Scratch by an Adopted Pekin Duck. J Investig Med High Impact Case Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40110910/

[34] Shalaby AG, Bakry NR, El-Demerdash AS. Virulence attitude estimation of Pasteurella multocida isolates in embryonated chicken eggs. Arch Microbiol. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34554268/

[35] Xiao J, Li Y, Hu Z, et al. Characterization of Pasteurella multocida isolated from ducks in China from 2017 to 2019. Microb Pathog. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34534643/